Pfizer
Kermit D Ervin, MBA, CPPM, PACS, is an experienced professional in the pharmaceutical industry, currently serving as Field Access Lead at Pfizer and Biohaven Pharmaceuticals since 2021, specializing in access and reimbursement education. Prior roles include Field Reimbursement Manager at Regeneron, focusing on access barrier removal and ongoing support for healthcare providers. Ervin has a strong background in payer relations management from GSK, where expertise in coding, billing, and patient access was developed across various therapeutic areas. With an extensive career at GlaxoSmithKline, starting in sales and advancing through various roles including Vaccines Access Manager, Ervin has demonstrated leadership and operational management skills. Early career experience includes supply chain management with UPS Supply Chain Solutions and logistics supervision at Roadway Express. Kermit D Ervin holds a BBA and MBA in Business Management from Mississippi State University.
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.